Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial

• Filip van den Bosch,
• Vibeke Strand,
• Cunshan Wang,
• Joseph C Cappelleri,
• Joseph Wu,
• Marina Magrey,
• James Cheng-Chung Wei,
• Victoria Navarro-Compán,
• Lisy Wang,
• Lara Fallon,
• Dona Fleishaker,
• Oluwaseyi Dina

Affiliations

Filip van den Bosch

Department of Rheumatology, Ghent University, VIB Center for Inflammation Research, Gent, Belgium

Vibeke Strand

Immunology/Rheumatology, Stanford University, Stanford, California, USA

Cunshan Wang

6 Global Product Development, Pfizer Inc, Groton, Connecticut, USA

Joseph C Cappelleri

Global Research and Development, Pfizer Inc, Groton, Connecticut, USA

Joseph Wu

6 Global Product Development, Pfizer Inc, Groton, Connecticut, USA

Marina Magrey

School of Medicine at Metrohealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA

James Cheng-Chung Wei

3 Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan

Victoria Navarro-Compán

Rheumatology, La Paz University Hospital, Madrid, Spain

Lisy Wang

4 Pfizer Inc, Groton, Connecticut, USA

Lara Fallon

Global Medical Affairs, Rheumatology, Pfizer Inc, Kirkland, Quebec, Canada

Dona Fleishaker

6 Global Product Development, Pfizer Inc, Groton, Connecticut, USA

Oluwaseyi Dina

7 Health Economics and Outcomes Research, Pfizer Inc, New York, New York, USA